ADAGENE ANNOUNCES NMPA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR ADG138, A NOVEL HER2XCD3 DOUBLE-MASKED BISPECIFIC T-CELL ENGAGER

Reuters · 3d ago

Please log in to view news